Trial
NCT02508324
IPA Targeted Adoptive Immunotherapy vs Adult Haplo-identical Cell Infusion During Induction of High Risk Leukemia
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Weill Medical College of Cornell University
Collaborators
New York Blood Center
Condition
Acute Myeloid Leukemia
Intervention
haplo-identical cells (donor)
Why stopped
Slow accrual and change in direction of cord blood program
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2024-02-13